Persistent mass after treatment for orbital rhabdomyosarcoma

PURPOSE: To report a case of orbital rhabdomyosarcoma and highlight the treatment approach to the dilemma of a residual mass. OBSERVATIONS: An eleven-year-old boy was diagnosed with Stage 1, Group III embryonal rhabdomyosarcoma in the orbit. After completing a 24-week treatment regimen of chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Siktberg, Jonathan C., Kovach, Alexandra E., Borinstein, Scott C., Correa, Hernan, Virgin, Frank W., Sobel, Rachel K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789529/
https://www.ncbi.nlm.nih.gov/pubmed/35106404
http://dx.doi.org/10.1016/j.ajoc.2022.101274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789529/
https://www.ncbi.nlm.nih.gov/pubmed/35106404
http://dx.doi.org/10.1016/j.ajoc.2022.101274

Ejemplares similares